Intrinsic value of Australian Clinical Labs Limited (ACL)

Live fair value data for Australian Clinical Labs Limited (ACL) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Downside: -4.0%

Margin of Safety: -4.2%

Current Price: $398.00

Valuation: Overvalued

Confidence: 4.0/10

Visual Bar

Market Price $398.00Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Intrinsic Value checker

Enter any ticker to open its intrinsic value analysis page.

Is Australian Clinical Labs Limited (ACL) undervalued or overvalued?

Based on the current model output, Australian Clinical Labs Limited appears to be overvalued with a downside of 4.00%.

Fair value vs market price — Australian Clinical Labs Limited (ACL)

Unlock premium access to view the live fair value comparison against current market price for ACL.

Frequently Asked Questions - ACL

How is ACL intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for ACL.

Is ACL undervalued or overvalued right now?

ACL is currently shown as overvalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for ACL: open their intrinsic value pages.

Explore Other Stocks